Contrasting Aclarion (NASDAQ:ACON) and Aeon Global Health (OTCMKTS:AGHC)

Aclarion (NASDAQ:ACON) and Aeon Global Health (OTCMKTS:AGHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, analyst recommendations, profitability, institutional ownership and earnings.

Institutional & Insider Ownership

7.5% of Aclarion shares are held by institutional investors. 0.8% of Aclarion shares are held by company insiders. Comparatively, 11.5% of Aeon Global Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Aclarion and Aeon Global Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0	1	0	0	2.00
Aeon Global Health	0	0	0	0	0.00

Aclarion presently has a consensus target price of $11,758.50, indicating a potential upside of 162,310.22%. Given Aclarion’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Aclarion is more favorable than Aeon Global Health.

Earnings & Valuation

This table compares Aclarion and Aeon Global Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$54,601.00	77.17	-$4.91 million	N/A	N/A
Aeon Global Health	N/A	N/A	N/A	N/A	N/A

Aeon Global Health has lower revenue, but higher earnings than Aclarion.

Profitability

This table compares Aclarion and Aeon Global Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aclarion	-12,845.05%	-422.87%	-201.15%
Aeon Global Health	N/A	N/A	N/A

About Aclarion

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.